Evaluation of a Protocol to Reduce Rectal Volume and Prostate Motion for External Beam Radiation Therapy of the Prostate

Journal of Medical Imaging and Radiation Sciences

Volumn 41, Issue 1, 2010, Pages 12-19

  Darud, Mike ^a   Giddings, Alison ^a   Keyes, Mira ^a   McGahan, Colleen ^a   Tyldesely, Scott ^a  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANALYTIC METHOD; ARTICLE; CLINICAL ARTICLE; CLINICAL EVALUATION; CLINICAL PROTOCOL; CONTROLLED STUDY; DEFECATION HABIT; EXTERNAL BEAM RADIOTHERAPY; HUMAN; IMAGE DISPLAY; INTESTINE MOTILITY; INTESTINE PREPARATION; MALE; PRIORITY JOURNAL; PROSTATE CANCER; TREND STUDY;

EID: 77949268322     PISSN: 19398654     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmir.2009.07.003     Document Type: Article

References (27)

1. Chung P.W., Haycocks T., Brown T., Cambridge Z., Kelly V., Alasti H., et al. On-line aSi portal imaging of implanted fiducial markers for the reduction of interfraction error during conformal radiotherapy of prostate carcinoma. Int J Radiat Oncol Biol Phys 60 1 (2004) 329-334
2. Beard C.J., Kijewski P., Bussiere M., Gelman R., Gladstone D., Shaffer K., et al. Analysis of prostate and seminal vesicle motion: implications for treatment planning. Int J Radiat Oncol Biol Phys 34 2 (1996) 451-458
3. Miralbell R., Taussky D., Rinaldi O., Lomax A., Canales S., Escude L., et al. Influence of rectal volume changes during radiotherapy for prostate cancer: a predictive model for mild-to-moderate late rectal toxicity. Int J Radiat Oncol Biol Phys 57 5 (2003) 1280-1284
4. Roeske J.C., Forman J.D., Mesina C.F., He T., Pelizzari C.A., Fontenla E., et al. Evaluation of changes in the size and location of the prostate, seminal vesicles, bladder, and rectum during a course of external beam radiation therapy. Int J Radiat Oncol Biol Phys 33 5 (1995) 1321-1329
5. de Crevoisier R., Tucker S.L., Dong L., Mohan R., Cheung R., Cox J.D., et al. Increased risk of biochemical and local failure in patients with distended rectum on the planning CT for prostate cancer radiotherapy. Int J Radiat Oncol Biol Phys 62 4 (2005) 965-973
6. Miralbell R., Ozsoy O., Pugliesi A., Carballo N., Arnalte R., Escude L., et al. Dosimetric implications of changes in patient repositioning and organ motion in conformal radiotherapy for prostate cancer. Radiother Oncol 66 2 (2003) 197-202
7. Zietman A.L., DeSilvio M.L., Slater J.D., Rossi Jr. C.J., Miller D.W., Adams J.A., et al. Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial. JAMA 294 10 (2005) 1233-1239
8. Dearnaley D.P., Sydes M.R., Graham J.D., Aird E.G., Bottomley D., Cowan R.A., et al. Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial. Lancet Oncol 8 6 (2007) 475-487
9. Kuban D.A., Tucker S.L., Dong L., Starkschall G., Huang E.H., Cheung M.R., et al. Long-term results of the M.D. Anderson randomized dose-escalation trial for prostate cancer. Int J Radiat Oncol Biol Phys 70 1 (2008) 67-74
10. Pollack A., Zagars G.K., Starkschall G., Antolak J.A., Lee J.J., Huang E., et al. Prostate cancer radiation dose response: results of the M.D. Anderson phase III randomized trial. Int J Radiat Oncol Biol Phys 53 5 (2002) 1097-1105
11. Peeters S.T., Heemsbergen W.D., van Putten W.L., Slot A., Tabak H., Mens J.W., et al. Acute and late complications after radiotherapy for prostate cancer: results of a multicenter randomized trial comparing 68 Gy to 78 Gy. Int J Radiat Oncol Biol Phys 61 4 (2005) 1019-1034
12. Dearnaley D.P., Hall E., Lawrence D., Huddart R.A., Eeles R., Nutting C.M., et al. Phase III pilot study of dose escalation using conformal radiotherapy in prostate cancer: PSA control and side effects. Br J Cancer 92 3 (2005) 488-498
13. van Herk M., Bruce A., Kroes A.P., Shouman T., Touw A., and Lebesque J.V. Quantification of organ motion during conformal radiotherapy of the prostate by three dimensional image registration. Int J Radiat Oncol Biol Phys 33 5 (1995) 1311-1320
14. Stasi M., Munoz F., Fiorino C., Pasquino M., Baiotto B., Marini P., et al. Emptying the rectum before treatment delivery limits the variations of rectal dose-volume parameters during 3DCRT of prostate cancer. Radiother Oncol 80 3 (2006) 363-370
15. Keros L., Bernier V., Aletti P., Marchesi V., Wolf D., and Noel A. Qualitative estimation of pelvic organ interactions and their consequences on prostate motion: study on a deceased person. Med Phys 33 6 (2006) 1902-1910
16. Nederveen A.J., Dehnad H., van der Heide U.A., van Moorselaar R.J., Hofman P., and Lagendijk J.J. Comparison of megavoltage position verification for prostate irradiation based on bony anatomy and implanted fiducials. Radiother Oncol 68 1 (2003) 81-88
17. Wu J., Haycocks T., Alasti H., Ottewell G., Middlemiss N., Abdolell M., et al. Positioning errors and prostate motion during conformal prostate radiotherapy using on-line isocentre set-up verification and implanted prostate markers. Radiother Oncol 61 2 (2001) 127-133
18. Poggi M.M., Gant D.A., Sewchand W., and Warlick W.B. Marker seed migration in prostate localization. Int J Radiat Oncol Biol Phys 56 5 (2003) 1248-1251
19. Byrne T.E. A review of prostate motion with considerations for the treatment of prostate cancer. Med Dosim 30 3 (2005) 155-161
20. Padhani A.R., Khoo V.S., Suckling J., Husband J.E., Leach M.O., and Dearnaley D.P. Evaluating the effect of rectal distension and rectal movement on prostate gland position using cine MRI. Int J Radiat Oncol Biol Phys 44 3 (1999) 525-533
21. Zelefsky M.J., Crean D., Mageras G.S., Lyass O., Happersett L., Ling C.C., et al. Quantification and predictors of prostate position variability in 50 patients evaluated with multiple CT scans during conformal radiotherapy. Radiother Oncol 50 2 (1999) 225-234
22. Melian E., Mageras G.S., Fuks Z., Leibel S.A., Niehaus A., Lorant H., et al. Variation in prostate position quantitation and implications for three-dimensional conformal treatment planning. Int J Radiat Oncol Biol Phys 38 1 (1997) 73-81
23. Lebesque J.V., Bruce A.M., Kroes A.P., Touw A., Shouman R.T., and van Herk M. Variation in volumes, dose-volume histograms, and estimated normal tissue complication probabilities of rectum and bladder during conformal radiotherapy of T3 prostate cancer. Int J Radiat Oncol Biol Phys 33 5 (1995) 1109-1119
24. Ten Haken R.K., Forman J.D., Heimburger D.K., Gerhardsson A., McShan D.L., Perez-Tamayo C., et al. Treatment planning issues related to prostate movement in response to differential filling of the rectum and bladder. Int J Radiat Oncol Biol Phys 20 6 (1991) 1317-1324
25. Crook J.M., Raymond Y., Salhani D., Yang H., and Esche B. Prostate motion during standard radiotherapy as assessed by fiducial markers. Radiother Oncol 37 1 (1995) 35-42
26. Antolak J.A., Rosen II, Childress C.H., Zagars G.K., and Pollack A. Prostate target volume variations during a course of radiotherapy. Int J Radiat Oncol Biol Phys 42 3 (1998) 661-672
27. Zellars R.C., Roberson P.L., Strawderman M., Zhang D., Sandler H.M., Ten Haken R.K., et al. Prostate position late in the course of external beam therapy: patterns and predictors. Int J Radiat Oncol Biol Phys 47 3 (2000) 655-660